Technical Analysis for PANC - Panacos Pharmaceuticals Inc

Grade Last Price % Change Price Change
grade C 0.0003 200.00% 0.0002
PANC closed up 200.0 percent on Friday, November 15, 2019, on 1.4 times normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.

Trend Table & Recent Signals

ADX Long-Term Intermediate-Term Short-Term
Weak or Absent N/A Up Up
See historical PANC trend table...

Date Alert Name Type % Chg
Crossed Above 20 DMA Bullish 0.00%
Crossed Above 50 DMA Bullish 0.00%
Expansion Pivot Buy Setup Bullish Swing Setup 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Reversal New Highs Setup Bullish Swing Setup 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Expansion Breakdown Bearish Swing Setup 200.00%
Jack-in-the-Box Bearish Bearish Swing Setup 200.00%

Older signals for PANC ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Panacos Pharmaceuticals, Inc. (Panacos) is a development-stage biotechnology company that seeks to develop next generation anti-infective products through the discovery and development of small-molecule oral drugs designed to treat human immunodeficiency virus (HIV) and other human viral diseases. The Company's lead product candidate, bevirimat, is an oral HIV drug candidate in Phase II clinical testing. Panacos has dosed over 485 patients and subjects with bevirimat and have seen a good safety and tolerability profile with no indication of a relationship between adverse events and drug levels. The Company has exclusive rights from University of North Carolina at Chapel Hill (UNC) to the United States patent claiming the chemical entity bevirimat. Panacos has an exclusive worldwide license with UNC for all indications.
Health Biotechnology Pharmaceutical Industry Health Sciences Hiv Hepatotoxins Chapel Hill Lentiviruses Anti Infective Products Human Viral Diseases University Of North Carolina

Is PANC a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Recent News

Indicators

Indicator Value
52 Week High 0.0011
52 Week Low 0.0001
Average Volume 17,123
200-Day Moving Average 0.0000
50-Day Moving Average 0.0002
20-Day Moving Average 0.0002
10-Day Moving Average 0.0002
Average True Range 0.0004
ADX 5.77
+DI 75.0000
-DI 58.3333
Chandelier Exit (Long, 3 ATRs ) -0.0009
Chandelier Exit (Short, 3 ATRs ) 0.0013
Upper Bollinger Band 0.0004
Lower Bollinger Band 0.0000
Percent B (%b) 0.75
BandWidth 200.0000
MACD Line -0.0001
MACD Signal Line 0.0000
MACD Histogram -0.0001
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.0006
Resistance 3 (R3) 0.0006 0.0004 0.0006
Resistance 2 (R2) 0.0004 0.0004 0.0005 0.0005
Resistance 1 (R1) 0.0004 0.0003 0.0004 0.0004 0.0005
Pivot Point 0.0002 0.0002 0.0003 0.0003 0.0002
Support 1 (S1) 0.0002 0.0002 0.0002 0.0002 0.0001
Support 2 (S2) 0.0000 0.0001 0.0001 0.0001
Support 3 (S3) 0.0000 0.0000 0.0001
Support 4 (S4) 0.0000